The Ketogenic Diet: A Metabolic Reset for Refractory Epilepsy
A comprehensive review in *The Lancet Neurology* synthesizes the clinical and mechanistic evidence for ketogenic diet therapies in epilepsy management. These diets, which shift metabolism from glucose to ketone bodies, demonstrate effectiveness in seizure control. The therapeutic action extends beyond simple fuel substitution, involving improvements in mitochondrial function, reductions in neuroinflammation, and modulation of key neurotransmitters. Furthermore, emerging research highlights a significant role for the gut microbiome, suggesting dietary-induced microbial changes can influence neurotransmitter balance and contribute to anti-seizure effects. While the classic ketogenic diet is highly effective, less restrictive variants like the modified Atkins diet offer greater flexibility and tolerability, making metabolic therapy a more viable option in diverse clinical and resource-limited settings.
Study Significance: This review underscores a paradigm where dietary intervention directly targets core pathological mechanisms like neuroinflammation and mitochondrial dysfunction, which are also central to many autoimmune and rheumatologic conditions. For rheumatologists, it reinforces the therapeutic potential of modulating systemic metabolism and the gut-joint axis, offering a conceptual framework for exploring nutritional strategies in managing inflammatory arthritis and related systemic autoimmune diseases. It prompts consideration of how similar metabolic shifts might influence disease activity scores, inflammatory markers like CRP, and the efficacy of conventional DMARDs or biologic therapies.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
